Biomarkers for psychosis and their genetic importance is a research project led by Dr Elvira Bramon that aims to identify new biomarkers and genetic risk factors for psychotic disorders. The project examines families affected by psychotic conditions, such as schizophrenia and bipolar disorders. We study cognitive dysfunction, and functional and structural brain changes, in both patients and healthy relatives, and seek to relate these measures with genetic variants identified in the affected individuals.
This project is funded by the Medical Research Council (MRC) and the Wellcome Trust.
Phenotypes & Association
This project aims to identify biological markers that we can use to understand disease mechanisms. If we investigate the biological pathways we will develop new treatments.
PEIC - Psychosis Endophenotyps International Consortium
International Collaborators
The biomarkers for psychosis and their genetic importance, is part of the Psychosis Endophenotype International Consortium (PEIC), a collaboration between multiple sites from world renowned universities and psychiatric genetics groups in Europe and the world. Partners in the collaboration have joint forces and share knowledge to enable large association analysis of traits related to psychosis. The PEIC initiative is founded by the MRC and the Wellome Trust, and includes research sites from United Kingdom, Holland, Germany, Spain, Australia, and USA.
Research Team
| Name | Position |
|---|---|
| Dr Elvira Bramon | Principal Investigator |
| Dr Alvaro Diez Revuelta | Marie Curie Fellow |
| Miss Siri Ranlund | PhD Student |
| Dr Stella Calafato | Clinical Training Fellow |
| Dr Johan Thygesen | Research Associate |
